These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 15532243)
1. [Early initiation of statin therapy in patients with acute myocardial infarction after successful percutaneous coronary intervention]. Katayama N; Nakao K; Horiuchi K; Ogawa H; Honda T J Cardiol; 2004 Oct; 44(4):131-40. PubMed ID: 15532243 [TBL] [Abstract][Full Text] [Related]
2. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level. Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547 [TBL] [Abstract][Full Text] [Related]
3. Impact of statin therapy on coronary intervention for non-ST elevation acute coronary syndrome with decreased low-density lipoprotein cholesterol. Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Shiba M; Wada M; Tsuji T; Komatsu H; Iijima R; Nakajima R; Yamamoto M; Yamamoto M; Yoshitama T; Takagi T; Hara H; Sugi K J Cardiol; 2007 Mar; 49(3):115-23. PubMed ID: 17444137 [TBL] [Abstract][Full Text] [Related]
4. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention. Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001 [TBL] [Abstract][Full Text] [Related]
5. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome. Chang SM; Yazbek N; Lakkis NM Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709 [TBL] [Abstract][Full Text] [Related]
6. Correlation of systemic inflammation with local inflammatory activity in non-culprit lesions: beneficial effect of statins. Toutouzas K; Drakopoulou M; Markou V; Karabelas I; Vaina S; Vavuranakis M; Tsiamis E; Tsioufis C; Androulakis A; Stefanadis C Int J Cardiol; 2007 Jul; 119(3):368-73. PubMed ID: 17258821 [TBL] [Abstract][Full Text] [Related]
7. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction]. Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101 [TBL] [Abstract][Full Text] [Related]
8. [Does percutaneous coronary intervention in non-culprit vessels improve the prognosis of acute myocardial infarction complicated by pump failure?]. Katayama N; Horiuchi K; Nakao K; Kasanuki H; Honda T J Cardiol; 2005 Jul; 46(1):1-8. PubMed ID: 16095225 [TBL] [Abstract][Full Text] [Related]
9. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome. Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539 [TBL] [Abstract][Full Text] [Related]
10. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy. Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP; J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964 [TBL] [Abstract][Full Text] [Related]
11. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study. Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365 [TBL] [Abstract][Full Text] [Related]
12. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl. Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D; Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369 [TBL] [Abstract][Full Text] [Related]
14. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study. Macin SM; Perna ER; Farías EF; Franciosi V; Cialzeta JR; Brizuela M; Medina F; Tajer C; Doval H; Badaracco R Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233 [TBL] [Abstract][Full Text] [Related]
15. Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. Leone AM; Rutella S; Giannico MB; Perfetti M; Zaccone V; Brugaletta S; Garramone B; Niccoli G; Porto I; Liuzzo G; Biasucci LM; Bellesi S; Galiuto L; Leone G; Rebuzzi AG; Crea F Int J Cardiol; 2008 Nov; 130(3):457-62. PubMed ID: 18667247 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention. Oduncu V; Erkol A; Kurt M; Tanboğa IH; Karabay CY; Şengül C; Bulut M; Özveren O; Fotbolcu H; Akgün T; Türkyilmaz E; Kırma C Int J Cardiol; 2013 Jul; 167(2):458-63. PubMed ID: 22305817 [TBL] [Abstract][Full Text] [Related]
17. Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Lev EI; Kornowski R; Vaknin-Assa H; Ben-Dor I; Brosh D; Teplitsky I; Fuchs S; Battler A; Assali A Am J Cardiol; 2009 Jan; 103(2):165-9. PubMed ID: 19121430 [TBL] [Abstract][Full Text] [Related]
18. C-reactive protein levels and outcomes after statin therapy. Ridker PM; Cannon CP; Morrow D; Rifai N; Rose LM; McCabe CH; Pfeffer MA; Braunwald E; N Engl J Med; 2005 Jan; 352(1):20-8. PubMed ID: 15635109 [TBL] [Abstract][Full Text] [Related]
19. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates. Baessler A; Fischer M; Huf V; Mell S; Hengstenberg C; Mayer B; Holmer S; Riegger G; Schunkert H Int J Cardiol; 2005 May; 101(2):293-8. PubMed ID: 15882678 [TBL] [Abstract][Full Text] [Related]
20. Effect of statin therapy prior to elective percutaneous coronary intervention on frequency of periprocedural myocardial injury. Mulukutla SR; Marroquin OC; Smith C; Varghese R; Anderson WD; Lee JS; Cohen HA; Counihan PJ; Lee AB; Gulati V; McNamara D Am J Cardiol; 2004 Dec; 94(11):1363-6. PubMed ID: 15566904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]